Location
United States, North America
Check Size
$100K - $5M
Investment Stage
Seed
Series A
Focus Areas
Health IT
Health & Hospital Services
Digital Health
BioTech
Consumer Health
Pharmaceuticals
Medical Devices
About Investor
Jenny Yip is Managing Partner at Adjuvant Capital. Adjuvant backs drugs, vaccines, diagnostics and medical devices addressing global health; the firm states it makes $10–$25 million investments and has led Seed/Series A rounds where mission-aligned. Yip’s background includes investment banking at Goldman Sachs and nonprofit board service in global health.
Previous investments
Antiva Biosciences
31M |2021
54gene
25M |2021
15M |2020
ChromaCode
10M |2020
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free